Cargando…

Novel and Emerging Therapies for Inflammatory Bowel Disease

Inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn’s disease are chronic, relapsing and remitting disorders of intestinal inflammation with potential systemic manifestations. Despite the availability of current biologics, such as anti-tumor necrosis factor (anti-TNF), anti-integr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Bawardy, Badr, Shivashankar, Raina, Proctor, Deborah D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080036/ https://www.ncbi.nlm.nih.gov/pubmed/33935763 http://dx.doi.org/10.3389/fphar.2021.651415

Ejemplares similares

The Impact of Inflammatory Bowel Disease Clinic On-site Vaccination Services
por: Hussain, Nadeen, et al.
Publicado: (2021)

Effect of obesity on vedolizumab response in inflammatory bowel disease
por: Levine, Louis J., et al.
Publicado: (2022)

Inflammatory bowel disease: Clinical screening and transition of care
por: Al-Bawardy, Badr
Publicado: (2017)

Impact of thiopurine dose in anti-tumor necrosis factor combination therapy on outcomes in inflammatory bowel disease
por: Nawaz, Ahmad, et al.
Publicado: (2023)

Use of Standardized Inflammatory Bowel Disease Endoscopy Scores in Clinical Practice
por: Gaidos, Jill K J, et al.
Publicado: (2023)

Novel Pharmacological Therapy in Inflammatory Bowel Diseases: Beyond Anti-Tumor Necrosis Factor
por: Pagnini, Cristiano, et al.
Publicado: (2019)

Emerging Therapies for Ulcerative Colitis: Updates from Recent Clinical Trials
por: AlAmeel, Turki, et al.
Publicado: (2023)

Precision Medicine in Inflammatory Bowel Diseases
por: Marafini, Irene, et al.
Publicado: (2021)

Microbial-Based Therapies in the Treatment of Inflammatory Bowel Disease – An Overview of Human Studies
por: Basso, Paulo José, et al.
Publicado: (2019)

Alterations and Potential Applications of Gut Microbiota in Biological Therapy for Inflammatory Bowel Diseases
por: Pu, Dan, et al.
Publicado: (2022)

Autophagy in intestinal fibrosis: relevance in inflammatory bowel disease
por: Macias-Ceja, Dulce C., et al.
Publicado: (2023)

Gut Microbiota Metabolism of Azathioprine: A New Hallmark for Personalized Drug-Targeted Therapy of Chronic Inflammatory Bowel Disease
por: Lazarević, Slavica, et al.
Publicado: (2022)

Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease
por: Duan, Linshan, et al.
Publicado: (2021)

Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease
por: Lichnog, Charlotte, et al.
Publicado: (2019)

Frontiers in Drug Research and Development for Inflammatory Bowel Disease
por: Currò, Diego, et al.
Publicado: (2017)

New Insights Into the Epigenetic Regulation of Inflammatory Bowel Disease
por: Xu, Jing, et al.
Publicado: (2022)

Deciphering the role of autophagy in the immunopathogenesis of inflammatory bowel disease
por: Li, Yue, et al.
Publicado: (2022)

The Placebo and Nocebo Responses in Clinical Trials in Inflammatory Bowel Diseases
por: Enck, Paul, et al.
Publicado: (2021)

Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases
por: Tominaga, Keiichi, et al.
Publicado: (2021)

Therapeutic Effect of Amomum villosum on Inflammatory Bowel Disease in Rats
por: Chen, Zhu, et al.
Publicado: (2018)

Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease: An Update
por: Tan, Pufang, et al.
Publicado: (2020)

Caspase-4 and -5 Biology in the Pathogenesis of Inflammatory Bowel Disease
por: Smith, Aoife P., et al.
Publicado: (2022)

Review of the Effects and Mechanism of Curcumin in the Treatment of Inflammatory Bowel Disease
por: Lin, Yuan, et al.
Publicado: (2022)

Hypoxia inducible factor prolyl hydroxylases in inflammatory bowel disease
por: Lun, Jie, et al.
Publicado: (2023)

Revisiting the Role of Thiopurines in Inflammatory Bowel Disease Through Pharmacogenomics and Use of Novel Methods for Therapeutic Drug Monitoring
por: Lim, Sheng Zhang, et al.
Publicado: (2018)

Emerging Therapies for Inflammatory Bowel Disease
por: Weisshof, Roni, et al.
Publicado: (2018)

Plant-Derived Alkaloids: The Promising Disease-Modifying Agents for Inflammatory Bowel Disease
por: Peng, Jiao, et al.
Publicado: (2019)

Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease Treatments
por: Lee, Scott D., et al.
Publicado: (2021)

Intestinal Macrophage Autophagy and its Pharmacological Application in Inflammatory Bowel Disease
por: Zheng, Yang, et al.
Publicado: (2021)

RIPK2 as a New Therapeutic Target in Inflammatory Bowel Diseases
por: Honjo, Hajime, et al.
Publicado: (2021)

Understanding and targeting centrally mediated visceral pain in inflammatory bowel disease
por: Farrell, Kristen E., et al.
Publicado: (2014)

Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease
por: Di Fusco, Davide, et al.
Publicado: (2019)

Role of Pyroptosis in Inflammatory Bowel Disease (IBD): From Gasdermins to DAMPs
por: Zhang, Shuxia, et al.
Publicado: (2022)

Medicinal plant-based drug delivery system for inflammatory bowel disease
por: Li, Ningcen, et al.
Publicado: (2023)

Saudi Arabia consensus guidance for the diagnosis and management of adults with inflammatory bowel disease
por: Mosli, Mahmoud H., et al.
Publicado: (2022)

An Update for Pharmacologists on New Treatment Options for Inflammatory Bowel Disease: The Clinicians’ Perspective
por: Schmidt, Carsten, et al.
Publicado: (2021)

Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases
por: Decara, Juan, et al.
Publicado: (2020)

Activation of PXR by Alpinetin Contributes to Abrogate Chemically Induced Inflammatory Bowel Disease
por: Yu, Zhilun, et al.
Publicado: (2020)

Traditional Chinese Medicine and Natural Products: Potential Approaches for Inflammatory Bowel Disease
por: Yuan, Shuo, et al.
Publicado: (2022)

Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention
por: Lucafò, Marianna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1sau3on9ikmbf7h22p6olslil5